Eurofins BioDiagnostics provides the livestock industry a range of tailored, high throughput genotyping solutions to help agribusinesses achieve their breeding goals faster and more economically. Whether your need is to discover the genetic basis of a high value trait, implement a genomic selection program or genotype your animals for a key marker, our services lab provides rapid and accurate testing results, backed by unmatched customer support.
The backbone of our services are built on industry leading technology platforms, including Axiom™ and Infinium™ microarray chemistries for discovery efforts and other high-density genotyping needs. For mid-density applications such as parentage analysis or marker assisted selection, we offer both AgriSeq™ and multiplex amplicon sequencing solutions leveraging NGS technology. For single or low-density genotyping studies, we offer qPCR and scaled endpoint PCR with the capability to generate over 100,000 data points per day. With a quick turn-around time of 2 to 3 weeks for most projects coupled with high throughput capabilities, we deliver results on time along with consultative services to explain your testing outcomes.
Eurofins offers unmatched value for your animal genomic testing needs. With our network of over 800 laboratories globally, working with Eurofins also provides access to an ecosystem of technology, testing expertise and logistics support both nationally and internationally. Our overarching vision and mission is to deliver our clients the optimum blend of innovative solutions, rapid results and best in industry customer support all at competitive service prices.
Whether focusing on US operations or leading a multinational effort, our team stands ready to assist your program. If you would like more information on our testing services, or to speak with our team about your specific requirements, please visit: https://www.eurofinsus.com/biodiagnostics/ or email: ebdiah@eurofinsus.com
* Axiom™, AgriSeq™ and Infinium™ are trademarks of Applied Biosystems and Illumina, respectively.
